Morgan McGlynn Carr is sharing the “earth-shattering” diagnosis to encourage others to check their breasts: “It could save a ...

Decision-making was influenced by patient values and did not vary by stage, race and ethnicity, or demographics.

Median Overall Survival (OS) of 13.9 months in triple negative breast cancer (TNBC) exceeds Trodelvy (11.8 months) and doubles control (6.9 months)OS of 17.3 months in HR+ metastatic breast cancer ...